Iodixanol

ADVERTISEMENT

Identification

Molecular formula
C35H44I6N6O15
CAS Number
92339-11-2
IUPAC Name
3-[[2-[2-[2-[2-(3-carboxy-2,4,6-triiodo-anilino)-2-oxo-ethoxy]ethoxy]ethoxy]acetyl]amino]-2,4,6-triiodo-benzoic acid
Molecular Weight
1550.20g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
2.0000g/cm3
Synonyms
iotroxic acid
Interesting facts

Interesting Facts about 3-[[2-[2-[2-[2-(3-carboxy-2,4,6-triiodo-anilino)-2-oxo-ethoxy]ethoxy]ethoxy]acetyl]amino]-2,4,6-triiodo-benzoic acid

This fascinating compound, often associated with imaging applications in medicine, exhibits a remarkable arrangement of atoms that makes it particularly useful in the field of radiology. Here are some noteworthy points about it:

  • Radiocontrast Agent: The presence of multiple iodine atoms in its structure lends this compound excellent X-ray-absorbing properties. This makes it a prime candidate for use as a radiocontrast agent in various imaging modalities.
  • Complex Structure: With a diverse chain of ethoxy groups and a carboxylic acid functionality, the compound showcases a complex architecture that contributes to its biological activity and efficacy as a contrast agent.
  • Applications in Medical Imaging: This compound plays a vital role in enhancing the visibility of vascular structures during imaging, aiding in accurate diagnosis and treatment planning.
  • Biocompatibility: The biocompatible nature of the compound is essential, ensuring minimal adverse reactions within the human body during procedures.
  • Research Potential: Ongoing studies continue to explore the efficacy of this compound in various diagnostic procedures, increasing its importance in both research and clinical settings.

In summary, the unique features and applications of 3-[[2-[2-[2-[2-(3-carboxy-2,4,6-triiodo-anilino)-2-oxo-ethoxy]ethoxy]ethoxy]acetyl]amino]-2,4,6-triiodo-benzoic acid underline its significant role in enhancing medical imaging, making it an exciting area of study for chemists and medical professionals alike.

ADVERTISEMENT